Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration.
about
Cold paresis in multifocal motor neuropathyMitochondrial defects in acute multiple sclerosis lesionsMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesNeuroprotection in a novel mouse model of multiple sclerosisAxonal degeneration as a self-destructive defense mechanism against neurotropic virus infectionPrimary progressive multiple sclerosis: progress and challenges.Wallerian degeneration in central nervous system: dynamic associations between diffusion indices and their underlying pathology.Inhibition of Listeria monocytogenes infection by neurological drugs.Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.Roles of channels and receptors in the growth cone during PNS axonal regeneration.Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.Energy failure in multiple sclerosis and its investigation using MR techniques.Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis.Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchangerGene therapy in autoimmune, demyelinating disease of the central nervous system.Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.The effect of smoking on the symptoms and progression of multiple sclerosis: a review.Preferential Recruitment of Neutrophils into the Cerebellum and Brainstem Contributes to the Atypical Experimental Autoimmune Encephalomyelitis Phenotype.Pathogenesis of Guillain-Barre syndrome.Axon loss is an important determinant of weakness in multifocal motor neuropathy.Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial.Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple SclerosisSodium channels and multiple sclerosis: roles in symptom production, damage and therapy.Astrocytes--friends or foes in multiple sclerosis?Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers.Cannabinoids in the management of spasticity associated with multiple sclerosis.Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.Electrophysiology in demyelinating polyneuropathies.Protecting axons in multiple sclerosis.Dietary patterns in clinical subtypes of multiple sclerosis: an exploratory studyTranslational research in neurology and neuroscience 2010: multiple sclerosisMitochondria as crucial players in demyelinated axons: lessons from neuropathology and experimental demyelination.Neurological perspectives on voltage-gated sodium channels.Neuroprotection and repair in multiple sclerosis.Polarization of macrophages and microglia in inflammatory demyelination.Pathophysiology of immune-mediated demyelinating neuropathies-part I: neuroscience.Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.
P2860
Q24628273-0360EDD1-28E9-4798-B4C3-5B6B59F058C7Q24648580-CC032B9E-4EAB-4905-8E5A-8F5458313FF9Q27023735-C4C40A7F-689A-41C1-856C-DB164AE4B744Q27302918-9BB84B24-6C1E-4598-A806-9B999955D632Q27487496-585D2E5E-4E94-499F-BE33-9249EA526B81Q30590258-DABD8373-7301-4964-8972-F6E45C523524Q31076922-55AECB1C-022A-49BB-BAD3-87F7E26D2CE8Q33520602-1EDF4BEB-612D-4311-B146-88DA0B08D08CQ33742402-EFE87F17-5097-4980-8E12-1C8E611100BEQ33771091-45E7C8D0-128D-468B-8836-C69FBFFE328CQ33919516-A01618E3-09F9-4A3D-B979-3879DF20964DQ33928808-D7A3DB35-6EFF-459F-92DF-164AAC6C5EF7Q34014627-A5A32C51-968B-4F2E-BCA2-A3AC41340EDBQ34236583-BEE97D3C-07A2-4A5D-ABDD-4AD17D70F2F2Q34321453-4637E1A4-1C43-438B-A802-26F99E678D6AQ35122159-6D042B40-170E-4080-B7A2-B46853BFD92CQ35485799-F17EF0B0-0E2B-4906-84F1-8C67D8865DB1Q35557367-4D6A69A3-25B8-427B-ABBE-D7E6BC0CED93Q35861951-80BB4FCC-6DE0-4513-8938-BA150E495F14Q35917297-139B2E81-DDCD-48E6-98BA-4325B71A3886Q36142106-C6EB8095-3BF2-43E4-9198-4A59082646D8Q36153387-990DAB0D-3073-4C74-A50A-F4115BDB9309Q36353053-6888B0E3-C197-4802-BC30-89F2D73DADF3Q36437641-F9AB85AD-2CDC-4D2F-BE88-FE7A64CD8AA8Q36744474-603F01D7-783D-4672-81C4-959CE34ED866Q36771880-39BFA942-F278-4430-B687-933FF129EDD2Q36878427-821D51D4-E29A-43AF-AD40-B631F7E811A1Q36979460-045607CF-2E33-46EB-8290-A824C7019BA7Q37062594-96A7824A-8E65-42F3-A8FE-609F874A4AAAQ37091141-762CBC4D-B26F-414C-B91F-197D2F315E86Q37111901-9B1C6221-0265-4132-8DDC-DD693C393BB3Q37218580-0956E11D-A9C7-43B8-9D0B-EEA9E97A984BQ37318138-A7D19FF6-1EAC-4061-941A-F479FB0092D4Q37772026-F398B84F-7FA0-4B89-BF40-3BAE160228BCQ37844421-883A5492-8439-48B4-BD8E-9C1A9D4660F9Q38042001-35857D95-DACF-4A4C-9CDB-358F06758FABQ38048610-D3E0D047-97CD-4D1E-BFA1-40CC00C40A54Q38096246-5E7A0F07-4AAB-4623-9DA1-B13E8EF3BB90Q38134344-03E78AF8-80F0-480A-A1C4-55B656C1DC9FQ38137792-8C5F1855-9150-49D0-A574-D3F0DABB87CC
P2860
Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Blockers of sodium and calcium ...... c oxide-mediated degeneration.
@en
Blockers of sodium and calcium ...... c oxide-mediated degeneration.
@nl
type
label
Blockers of sodium and calcium ...... c oxide-mediated degeneration.
@en
Blockers of sodium and calcium ...... c oxide-mediated degeneration.
@nl
prefLabel
Blockers of sodium and calcium ...... c oxide-mediated degeneration.
@en
Blockers of sodium and calcium ...... c oxide-mediated degeneration.
@nl
P2093
P356
P1433
P1476
Blockers of sodium and calcium ...... c oxide-mediated degeneration.
@en
P2093
Kenneth J Smith
Meirion Davies
Paul A Blaker
Raju Kapoor
Susan M Hall
P304
P356
10.1002/ANA.10443
P577
2003-02-01T00:00:00Z